title: Central role of alpha9 acetylcholine receptor in coordinating keratinocyte adhesion and motility at the initiation of epithelialization.
abstract: Epithelialization, a major component of wound healing, depends on keratinocyte adhesion and migration. Initiation of migration relies upon the ability of keratinocytes to free themselves from neighboring cells and basement membrane. The local cytotransmitter acetylcholine (ACh) controls keratinocyte adhesion and locomotion through different classes of ACh receptors (AChR). In this study, we explored signaling pathways downstream of the alpha9 AChR subtype that had been shown to control cell shape and cytoplasm mobility. Inactivation of alpha9 signaling by pharmacologic antagonism and RNA interference in keratinocyte cultures and null mutation in knockout mice delayed wound re-epithelialization in vitro and in vivo, respectively, and diminished the extent of colony scattering and cell outgrowth from the megacolony. Although keratinocytes at the leading edge elongated, produced filopodia and moved out, most of them remained anchored to the substrate by long cytoplasmic processes that stretched during their migration instead of retracting the uropod. Since the velocity of keratinocyte migration was not altered, we investigated the role of alpha9 in assembly/disassembly of the cell-cell and cell-matrix adhesion complexes. Stimulation of alpha9 upregulated in a time-dependent fashion phosphorylation of the adhesion molecules comprising focal adhesions (FAK, paxillin) and intercellular junctions (beta-catenin, desmoglein 3) as well as cytokeratins. Stimulation of alpha9 was associated with activation of phospholipase C, Src, EGF receptor kinase, protein kinase C, Rac and Rho, whereas inhibition of this receptor interfered with phosphorylation of adhesion and cytoskeletal proteins, and also altered cell-cell cohesion. We conclude that signaling through alpha9 AChR is critical for completion of the very early stages of epithelialization. By activating alpha9 AChR, ACh can control the dynamics and strength of cell-cell cohesion, disabling of a trailing uropod and disassembly and reassembly of focal adhesions, thus facilitating crawling locomotion.
authors: Department of Dermatology, University of California Irvine, C340 Medical Sciences I, Irvine, CA 92697, USA.
authors: Alex I
authors: AI
authors: Chernyavsky
authors: Juan
authors: J
authors: Arredondo
authors: Douglas E
authors: DE
authors: Vetter
authors: Sergei A
authors: SA
authors: Grando
mesh_terms: D000818:Animals; D002448:Cell Adhesion / Q000187:drug effects; D002465:Cell Movement / Q000187:drug effects; D003598:Cytoskeletal Proteins / Q000378:metabolism; D004848:Epithelium / Q000187:drug effects / Q000378:metabolism*; D017228:Hepatocyte Growth Factor / Q000494:pharmacology; D006801:Humans; D007231:Infant, Newborn; D015603:Keratinocytes / Q000166:cytology* / Q000187:drug effects / Q000201:enzymology; D051379:Mice; D010641:Phenotype; D010766:Phosphorylation / Q000187:drug effects; D011505:Protein-Tyrosine Kinases / Q000378:metabolism; D011978:Receptors, Nicotinic / Q000378:metabolism*; D013997:Time Factors; D014945:Wound Healing / Q000187:drug effects
chemical_list: D003598:Cytoskeletal Proteins; D011978:Receptors, Nicotinic; C443079:nAChR alpha9; D017228:Hepatocyte Growth Factor; D011505:Protein-Tyrosine Kinases
references: J Biol Chem. 2005 Nov 25;280(47):39220-8
references: 16150734
references: Brain Res. 1984 Dec 24;324(2):305-12
references: 6529621
references: J Invest Dermatol. 1996 Apr;106(4):590-7
references: 8617990
references: J Cell Biol. 1999 Nov 29;147(5):1009-22
references: 10579721
references: Am J Pathol. 2000 Oct;157(4):1377-91
references: 11021840
references: J Neurosci. 2005 Nov 23;25(47):10905-12
references: 16306403
references: J Invest Dermatol. 1993 Dec;101(6):804-10
references: 8245509
references: J Cell Sci. 2004 Aug 1;117(Pt 17):3759-68
references: 15252114
references: Cell Motil Cytoskeleton. 1995;30(2):108-21
references: 7606804
references: Exp Cell Res. 2004 Apr 1;294(2):534-49
references: 15023540
references: Curr Opin Cell Biol. 2003 Oct;15(5):590-7
references: 14519394
references: J Cell Sci. 2004 Mar 15;117(Pt 8):1339-50
references: 14996911
references: Skin Pharmacol. 1993;6(2):135-47
references: 8352951
references: Nat Cell Biol. 2003 Mar;5(3):236-41
references: 12598902
references: Cell Motil Cytoskeleton. 2003 May;55(1):14-25
references: 12673595
references: Mol Cell Biol. 1997 Dec;17(12):6906-14
references: 9372922
references: Cell Calcium. 2006 Apr;39(4):349-55
references: 16451809
references: Biochem J. 2005 Oct 15;391(Pt 2):359-70
references: 15975092
references: FASEB J. 2006 Oct;20(12):2093-101
references: 17012261
references: Mol Biol Cell. 2002 Jun;13(6):1857-70
references: 12058054
references: Eur J Immunol. 1999 Jul;29(7):2233-40
references: 10427986
references: J Invest Dermatol. 2004 Nov;123(5):937-49
references: 15482483
references: Mol Pharmacol. 2002 Jan;61(1):150-9
references: 11752216
references: Cell Adhes Commun. 1999;7(2):125-38
references: 10427965
references: Br J Dermatol. 1990 Jun;122(6):777-84
references: 2369558
references: Curr Opin Cell Biol. 1999 Apr;11(2):274-86
references: 10209151
references: Neuropharmacology. 2000 Oct;39(13):2515-24
references: 11044723
references: J Invest Dermatol. 1999 Jan;112(1):67-71
references: 9886266
references: Cell. 1994 Nov 18;79(4):705-15
references: 7954834
references: Neuron. 1999 May;23(1):93-103
references: 10402196
references: Cell Death Differ. 1996 Oct;3(4):357-71
references: 17180106
references: Acta Otolaryngol. 1999 Mar;119(2):185-8
references: 10320073
references: J Cell Sci. 2004 Nov 1;117(Pt 23):5665-79
references: 15494367
references: Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3501-6
references: 11248107
references: Front Biosci. 2002 Jan 1;7:d143-50
references: 11779709
references: J Cell Biol. 1989 Oct;109(4 Pt 1):1495-509
references: 2677020
references: J Cell Physiol. 1998 Aug;176(2):255-65
references: 9648913
references: J Biol Chem. 2002 May 24;277(21):18694-702
references: 11907028
references: J Invest Dermatol. 1976 Jul;67(1):39-57
references: 778296
references: J Cell Biol. 2006 Dec 4;175(5):721-7
references: 17130286
references: Mol Pharmacol. 2003 May;63(5):1067-74
references: 12695535
references: Endocrinology. 2002 Mar;143(3):744-6
references: 11861491
references: Mol Pharmacol. 1973 Sep;9(5):630-9
references: 4788157
references: J Cell Biol. 2002 Oct 28;159(2):325-36
references: 12391028
references: J Cell Sci. 2003 Sep 1;116(Pt 17):3543-56
references: 12865436
references: J Invest Dermatol. 1997 Apr;108(4):482-7
references: 9077478
references: Mol Pharmacol. 1999 Feb;55(2):248-54
references: 9927615
references: J Investig Dermatol Symp Proc. 1999 Sep;4(2):137-44
references: 10536988
references: Mol Cell Biol. 2004 Dec;24(24):10558-72
references: 15572663
references: J Cell Biol. 2004 Jul 19;166(2):261-72
references: 15263021
references: J Neurosci Res. 1996 May 15;44(4):350-4
references: 8739154
references: J Cell Biol. 1999 Mar 22;144(6):1235-44
references: 10087266
references: J Cell Sci. 1997 Jan;110 ( Pt 1):23-33
references: 9010781
references: J Invest Dermatol. 2006 Sep;126(9):1948-65
references: 16912692
references: Hear Res. 2000 Mar;141(1-2):117-28
references: 10713500
references: J Biol Chem. 2004 Jul 2;279(27):27965-70
references: 15107421
references: Cell Adhes Commun. 1998 Jan;5(1):1-12
references: 9638337
references: Exp Cell Res. 2004 Feb 1;293(1):1-13
references: 14729052
references: J Invest Dermatol. 2006 Nov;126(11):2458-72
references: 16810300
references: J Physiol Paris. 1998 Oct-Dec;92(5-6):345-9
references: 9789835
references: J Comp Neurol. 1996 May 20;369(1):31-55
references: 8723701
references: Genomics. 2001 May 1;73(3):272-83
references: 11350119
references: Nat Rev Cancer. 2002 Jun;2(6):442-54
references: 12189386
references: Exp Dermatol. 2006 Apr;15(4):265-82
references: 16512874